Evolyutsiya Programm Kombinirovannogo Lecheniya Limfomy Khodzhkina
| AUTHOR | Datsenko Pavel |
| PUBLISHER | LAP Lambert Academic Publishing (05/15/2012) |
| PRODUCT TYPE | Paperback (Paperback) |
Description
Razrabotannaya v RNTsRR klassifikatsiya otsenki effektivnosti khimioterapii I linii pri LKh pokazala bol'shuyu effektivnost' v predskazanii retsidivov po sravneniyu s kriteriyami RECIST. Naibolee udobnoy i informativnoy predstavlyaetsya otsenka protivoopukholevogo otveta u kazhdogo patsienta po odnoy iz zon s naimen'shim effektom posle lekarstvennogo etapa lecheniya. Obrashchaet vnimanie otsutstvie kakikh-libo razlichiy v podgruppakh s "CR" i "PR 80%," kotorye mozhno ob"edinit' v gruppu "adekvatnogo otveta." Dostovernoe snizhenie pokazateley vyzhivaemosti pri "PR 0-79%" svidetel'stvuet o vazhnosti vydeleniya dannoy gruppy po kriteriyu nizkogo protivoopukholevogo otveta pod obshchim nazvaniem "neadekvatnyy otvet." Osnovnoy zadachey sovremennykh protokolov khimioterapii I linii pri LKh, s nashey tochki zreniya, yavlyaetsya snizhenie protsenta patsientov s khimiorezistentnymi formami zabolevaniya i neadekvatnym otvetom (PR: 0 - 79%). V tselom, opukholevye kletki dolzhny byt' ubity cherez dva mesyatsa posle nachala khimioterapii, esli udalos' dobit'sya ochen' rannego otveta - eto luchshiy biologicheskiy pokazatel' uspekha."
Show More
Product Format
Product Details
ISBN-13:
9783848485284
ISBN-10:
3848485281
Binding:
Paperback or Softback (Trade Paperback (Us))
Content Language:
Russian
More Product Details
Page Count:
68
Carton Quantity:
116
Product Dimensions:
6.00 x 0.16 x 9.00 inches
Weight:
0.25 pound(s)
Country of Origin:
US
Subject Information
BISAC Categories
Medical | General
Descriptions, Reviews, Etc.
publisher marketing
Razrabotannaya v RNTsRR klassifikatsiya otsenki effektivnosti khimioterapii I linii pri LKh pokazala bol'shuyu effektivnost' v predskazanii retsidivov po sravneniyu s kriteriyami RECIST. Naibolee udobnoy i informativnoy predstavlyaetsya otsenka protivoopukholevogo otveta u kazhdogo patsienta po odnoy iz zon s naimen'shim effektom posle lekarstvennogo etapa lecheniya. Obrashchaet vnimanie otsutstvie kakikh-libo razlichiy v podgruppakh s "CR" i "PR 80%," kotorye mozhno ob"edinit' v gruppu "adekvatnogo otveta." Dostovernoe snizhenie pokazateley vyzhivaemosti pri "PR 0-79%" svidetel'stvuet o vazhnosti vydeleniya dannoy gruppy po kriteriyu nizkogo protivoopukholevogo otveta pod obshchim nazvaniem "neadekvatnyy otvet." Osnovnoy zadachey sovremennykh protokolov khimioterapii I linii pri LKh, s nashey tochki zreniya, yavlyaetsya snizhenie protsenta patsientov s khimiorezistentnymi formami zabolevaniya i neadekvatnym otvetom (PR: 0 - 79%). V tselom, opukholevye kletki dolzhny byt' ubity cherez dva mesyatsa posle nachala khimioterapii, esli udalos' dobit'sya ochen' rannego otveta - eto luchshiy biologicheskiy pokazatel' uspekha."
Show More
Your Price
$62.84